
Eradibact 1.5 Injection
Marketer
Mediwood Healthcare Pvt Ltd
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Eradibact 1.5 Injection
Combactin 1.5 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Ample rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your physician may order laboratory and diagnostic tests to monitor treatment response.
Primary Ingredients of Eradibact 1.5 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Eradibact 1.5 Injection
Managing bacterial illnesses
Major Benefits of Eradibact 1.5 Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Eradibact 1.5 Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Eradibact 1.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Eradibact 1.5 Injection works:
Eradibact 1.5 Injection merges Cefoperazone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Cefoperazone's antimicrobial effect.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Eradibact 1.5 Injection therapy can lead to adverse effects including facial redness, rapid pulse, queasiness, dehydration, pectoral discomfort, and hypotension (a Disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Pregnancy use of Eradibact 1.5 Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Eradibact 1.5 Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, suggesting no infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of Eradibact 1.5 Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Eradibact 1.5 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Eradibact 1.5 Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Eradibact 1.5 Injection :
Should you omit a scheduled dose of Eradibact 1.5 Injection, seek medical advice.
Facts to Know About Eradibact 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
